Posts in category Healthcare


Cowen Sings the Praises of Genocea Biosciences Inc (GNCA) Following Positive GEN-003 Phase 2b Data

Cowen analyst Phil Nadeau is out with a bullish note on shares of Genocea Biosciences Inc (NASDAQ:GNCA), …

Read more

Why Endo International plc (ENDP) Shares Could Remain Range-Bound

In a research report released Monday, Oppenheimer analyst Derek Archila reiterated a Perform rating on …

Read more

Genocea Biosciences Inc (GNCA): This Analyst Turns Bullish, Sets $12 Target Price

In a research report issued Monday, Needham analyst Alan Carr upgraded shares of Genocea Biosciences Inc (NASDAQ:GNCA), …

Read more

Analysts Remain Buyers of 2 Volatile Healthcare Stocks: Cytori Therapeutics Inc (CYTX) and TearLab Corp (TEAR)

Cytori Therapeutics Inc: Should You Catch This Falling Knife? Cytori Therapeutics Inc (NASDAQ:CYTX) shares are crashing …

Read more

J.P. Morgan Comments on Gilead Sciences, Inc. (GILD) Following Clinical Results in HIV

J.P. Morgan analyst Cory Kasimov is out today with a new research note on Gilead Sciences, Inc. …

Read more

AEterna Zentaris Inc. (USA) (AEZS) CEO’s Departure Raises Questions

AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) shares are tumbling nearly 7% in Monday’s trading session, following …

Read more

William Blair Bullish on Biotech: Sarepta Therapeutics Inc (SRPT), Dynavax Technologies Corporation (DVAX), and Exelixis, Inc. (EXEL)

Sarepta’s $12+ Million 2Q Beat Sarepta Therapeutics Inc (NASDAQ:SRPT) Duchenne muscular dystrophy (DMD) drug Exondys …

Read more

Top Analyst Lifts Price Target for Intuitive Surgical, Inc. (ISRG) on Back of Strong 2Q Results

Canaccord analyst Jason Mills is out today with a bullish research note on Intuitive Surgical, Inc. …

Read more

Biotech Bulletin of the Week: Gilead Sciences, Inc. (GILD), Vertex Pharmaceuticals Incorporated (VRTX), and Keryx Biopharmaceuticals (KERX)

Gilead’s FDA-Approved Drug Still Faces an Uphill Battle in HCV Ring Gilead Sciences, Inc. (NASDAQ:GILD) …

Read more

Sarepta Therapeutics Inc’s (SRPT) Earnings Trigger Price Target Boost; Shares Soar 18%

Sarepta Therapeutics Inc (NASDAQ:SRPT) shares are soaring nearly 18% in pre-market trading Thursday, after the …

Read more